Announcements Trials

Browse Landscape

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Mesothelioma 1 Medulloblastoma 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Oxaliplatin 269 Bevacizumab 259 Fluorouracil 248 Irinotecan 240 Leucovorin 217 Capecitabine 196 Cetuximab 160 Colonoscopy 74 Folfox protocol 70 Panitumumab 64 regorafenib 62 Drug Therapy 52 Radiotherapy 50 HMPL-013 50 Blood Specimen Collection 45 trifluridine tipiracil drug combination 43 pembrolizumab 41 Surveys and Questionnaires 35 Standard of Care 34 Nivolumab 34 Neoadjuvant Therapy 34 Surgical Procedures, Operative 33 Magnetic Resonance Spectroscopy 30 IFL protocol 27 Trifluridine 26 Interviews as Topic 26 Celecoxib 26 XELOX 25 Early Intervention, Educational 24 Methods 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Neoplasms × Histocompatibility Testing × Clear all

NCT05661292 2023-01-26

COLOFIT

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡